The hormonal symphony.
Thyroid dysfunction, perimenopause, menopause, postmenopause. Four life stages, four sets of biomarkers, four common patterns of misdiagnosis, and one protocol that adapts across them. Read the part that matches where you are.
Part 1. Thyroid dysfunction.
Thyroid dysfunction is where most midlife women first encounter the mismatch between what they know is happening in their bodies and what a standard NHS blood panel is willing to acknowledge. Fatigue, weight gain, cold intolerance, thinning hair, brain fog, mood shifts. The panel comes back "in range," and the story ends there. The panel that actually reveals thyroid function is more nuanced than TSH alone.
The full picture requires TSH, free T4, free T3, reverse T3, and thyroid antibodies (TPO and TG). A TSH inside the reference range with low free T3 tells a completely different story from a TSH inside the reference range with balanced conversion. Antibodies signal Hashimoto's or Graves' well before the picture is symptomatic enough for medication. The protocol response depends on the pattern, not on a single number.
Part 1 draft to be extended with Maria's clinical preferences: which private labs she uses in the UK, her preferred approach when NHS panels come back "normal" but symptoms persist, and any case-file numbers she is comfortable publishing.
Part 2. Perimenopause.
Perimenopause is not a switch that flips. It is a decade of shifting hormonal patterns, typically starting somewhere in the late 30s or early 40s and running until periods stop for twelve consecutive months. During that decade oestrogen becomes erratic rather than declining smoothly, progesterone drops earlier and faster than most women are told, and the resulting mismatch is the biochemistry behind most of the "I don't feel like myself" complaints of the perimenopausal decade.
What the biomarkers show, when you know to look for it, is a story of luteal-phase progesterone insufficiency well before any period changes register. FSH starts climbing, but variably. Cortisol and thyroid function often destabilise in parallel, which is why perimenopausal women get diagnosed with thyroid problems and adrenal-fatigue narratives that miss the underlying hormonal shift.
Part 2 draft to be extended with Maria's clinical approach to perimenopausal panels (DUTCH test? saliva? blood? day-21 progesterone?) and how she structures the reversal work during this stage.
Part 3. Menopause.
Menopause is a single day, twelve months after your last period. Everything before it is perimenopause; everything after is postmenopause. The day itself is a demographic marker, not a clinical event. What matters is what the hormonal environment looks like on either side of it and how much of the symptom load is being driven by declining oestrogen and progesterone versus the metabolic changes that arrive in parallel.
The evidence base for HRT has shifted substantially in the last decade. Body-identical hormones through a competent GP or menopause specialist are the standard of care for most women who are symptomatic. Maria's practice does not prescribe HRT, but the protocol runs alongside it and addresses the metabolic and nutritional levers that HRT alone will not touch, particularly insulin resistance, bone density, cardiovascular risk, and cognitive function.
Part 3 draft to be extended with Maria's view on HRT in principle (support of, referral pattern), her nutritional priorities during the menopausal transition, and what she typically works on alongside a client's GP or menopause specialist.
Part 4. Postmenopause and the immune-modulating protocol.
Postmenopause is a permanent hormonal state, not a transient one, and the health work in this decade is about long-term maintenance rather than symptom management. The two biggest metabolic shifts are increased cardiovascular risk, driven by loss of oestrogen's protective effect on the vasculature, and increased insulin-resistance risk, driven partly by hormonal shift and partly by declining muscle mass and physical activity.
Maria's immune-modulating protocol runs across the postmenopausal decade and addresses both. It focuses on gut health as the ground everything else grows from (in Ayurvedic terms, अग्नि agni, the digestive fire that determines what actually gets absorbed and used), on strength training as the lever for insulin sensitivity and bone density, and on targeted nutritional support for inflammation control. What the protocol is building, over years rather than months, is ओजस् ojas, the Ayurvedic term for the vitality reserve that carries you through late-life health. The full protocol structure is bespoke to each client, but the shape of it is consistent enough to describe as a repeatable framework.
Part 4 draft to be extended with Maria's actual IM protocol structure (what "immune-modulating" means to her clinically, which nutritional inputs she prioritises, how she measures progress). Existing post already covers this in outline, needs the current writeup mapped in.
Working with thyroid or midlife hormonal shifts?